THE MILLION WOMEN STUDY

Rejuvime Medical • October 7, 2015

The Million Women Study was conducted by The University of Oxford with the goal of recruiting women in the UK to answer the following questions:

What effects do combined oestrogen and progestagen hormone replacement therapy (HRT) preparations have on breast cancer risk?

Are breast cancers detected at screening in women who have used HRT or oral contraceptives different in terms of size and invasiveness from the cancers detected in women who have never used these hormones?

How does HRT use affect the efficacy of breast cancer screening?

How does HRT use affect mortality from breast cancer and other conditions?

Visit the link below to view the current progress of this study:

#‎rejuvimemedical‬ ‪#‎lookyounger‬ ‪#‎feelyounger‬ ‪#‎liveyounger‬ ‪#‎bioidenticalhormones‬ ‪#‎hormonereplacement‬

 

The post THE MILLION WOMEN STUDY first appeared on Rejuvime Medical.

Get in Touch

Questions? Contact us today by phone or book an appointment online.

Questions? Call our office:

(225) 228-3128

Rejuvime provides individualized care, evidence-based treatment, and compassionate support to women
By Rejuvime Medical November 13, 2025
The FDA has removed the black box warning on estrogen after new evidence shows HRT can be safe and beneficial. Learn what changed and how Rejuvime tailors treatment to each patient.
Menopause can lead to changes in libido for women.
By Rejuvime Medical October 31, 2025
Low libido after 40? Learn how menopause affects sexual desire and how hormone replacement therapy (HRT) can reignite energy, confidence, and intimacy.
Increase energy and support metabolic health with GLP-1 Medication
By Rejuvime Medical October 29, 2025
GLP-1 medications do more than manage blood sugar. They improve insulin sensitivity, reduce inflammation, and support overall metabolic health even in people without diabetes.
Show More